Analysis of molecular alterations in left- and right-sided colorectal carcinomas reveals distinct pathways of carcinogenesis: proposal for new molecular profile of colorectal carcinomas.

The Journal of Molecular Diagnostics : JMD
Tamotsu SugaiShin-ichi Nakamura

Abstract

To clarify distinct genetic profiles of colorectal cancers based on tumor location (left- and right-sided), we evaluated the status of loss of heterozygosity (LOH), CpG islands methylation phenotype (CIMP), microsatellite instability (MSI), and mutations of p53, Ki-ras, and APC genes in 119 colorectal cancers. Statuses of LOH (at 5q, 8p, 17p, 18q, and 22q), MSI, and CIMP (MINT1, MINT2, MINT31, MLH-1, MGMT, p14, p16, and RASSF1A) were determined using microsatellite polymerase chain reaction and methylation-specific polymerase chain reaction coupled with a crypt isolation method, respectively. In addition, mutations of p53, Ki-ras, and APC genes were also examined. LOH, MSI, and CIMP status allowed us to classify samples into two groups: low or negative and high or positive. Whereas the frequency of p53 mutations in the LOH-high status was significantly higher in left-sided cancers than in right-sided cancers, CIMP-high in the LOH-high status and MSI-positive status were more frequently found in right-sided cancers compared with left-sided cancers. Finally, location-specific methylated loci were seen in colorectal cancers: type I (dominant in right-sided cancer) and type II (common in both segments of cancer). Our data confirm t...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Sep 1, 1988·The New England Journal of Medicine·B VogelsteinJ L Bos
Apr 10, 1997·Nature·C LengauerB Vogelstein
Jan 8, 1998·International Journal of Cancer. Journal International Du Cancer·J BreivikG Gaudernack
Jan 1, 1999·Nature·C LengauerB Vogelstein
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M ToyotaJ P Issa
Oct 29, 2000·The American Journal of Gastroenterology·W A BleekerJ T Plukker
Nov 4, 2000·International Journal of Cancer. Journal International Du Cancer·T SugaiC Itoh
Jan 10, 2001·Current Opinion in Oncology·A Lindblom
Sep 11, 2001·The American Journal of Pathology·A RashidS R Hamilton
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Wade S SamowitzMartha L Slattery
May 10, 2002·The American Journal of Pathology·Annie On-On ChanAsif Rashid
Jul 3, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gillian SmithC Roland Wolf
Aug 29, 2002·Gastroenterology·Jeremy R JassBarbara A Leggett
Sep 7, 2002·International Journal of Cancer. Journal International Du Cancer·Barry Iacopetta
Nov 2, 2002·The Journal of Molecular Diagnostics : JMD·Tamotsu SugaiMotohiro Ishii
Feb 21, 2004·Carcinogenesis·Margreet LüchtenborgAnton F P M de Goeij

❮ Previous
Next ❯

Citations

Aug 13, 2013·Current Gastroenterology Reports·Michael Tadros, Joseph C Anderson
Jan 1, 2010·Journal of the National Cancer Institute·Hermann BrennerUlrike Haug
Jan 1, 2010·Journal of the National Cancer Institute·Nancy N Baxter, Linda Rabeneck
Feb 1, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Joo Mi YiNita Ahuja
Jun 7, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christopher G SmithJeremy P Cheadle
Oct 16, 2007·BMC Cancer·Anders LorentzenCathy Mitchelmore
Aug 10, 2012·American Journal of Public Health·Amanda I PhippsPolly A Newcomb
Aug 19, 2007·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Francesco Di FabioMark Trifiro
May 21, 2014·Digestive Diseases and Sciences·Amy L CisykKirk J McManus
Nov 17, 2009·Gastroenterology·Hermann BrennerMichael Hoffmeister
Dec 15, 2015·Expert Review of Molecular Diagnostics·Kinga TóthBéla Molnár
Feb 5, 2016·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Petros Christakis Papagiorgis
May 7, 2014·BioMed Research International·Inés OmraneAmel Benammar-Elgaaied
Sep 18, 2008·International Journal of Cancer. Journal International Du Cancer·Yong Ho KimYoung S Kim
May 1, 2015·International Journal of Colorectal Disease·Takahiro HorimatsuHisao Tajiri
May 20, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Guoren DengYoung S Kim
Mar 20, 2014·Cancer Biology & Therapy·Joanna H M TongKa Fai To
Feb 24, 2015·Frontiers in Oncology·Francesco CaiazzaKieran Sheahan
Dec 10, 2014·Cancer Causes & Control : CCC·Xu Yao, Zhong Tian
Oct 6, 2012·Nutrition and Cancer·Helen F ClapinJane S Heyworth
Oct 6, 2016·Journal of Gastroenterology·Tamotsu SugaiTakayuki Matsumoto
Dec 7, 2016·Nature Reviews. Clinical Oncology·Cornelis J A PuntLouis Vermeulen
Mar 23, 2017·Clinical Endoscopy·Yu Mi Lee, Kyu Chan Huh
Feb 23, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mayank JauhriShyam Aggarwal
Feb 21, 2009·Inflammatory Bowel Diseases·M M H ClaessenF P Vleggaar
Aug 19, 2007·Journal of Clinical Gastroenterology·Elizabeth T JacobsMaría Elena Martínez
Feb 24, 2010·International Journal of Cancer. Journal International Du Cancer·Tamotsu SugaiKazuyuki Suzuki
Apr 21, 2011·Expert Review of Anticancer Therapy·Richard M HoffmanRobert L Rhyne
Dec 17, 2009·Diseases of the Colon and Rectum·Frank BenedixUNKNOWN Colon/Rectum Carcinomas (Primary Tumor) Study Group
Dec 19, 2019·Journal of the National Cancer Institute·Paul R BarberTony Ng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.